Rocket Lab Corp (RKLB) director sells 15,000 shares at $65 on 12/12/2025

Rhea-AI Filing Summary

Rocket Lab Corp director Merline Saintil reported a stock sale. On 12/12/2025, Saintil sold 15,000 shares of Rocket Lab common stock at $65 per share in a disposition coded “S.” After this transaction, Saintil directly owned 398,529 shares of Rocket Lab common stock.

Insider Trade Summary

Net Seller: 15,000 shares

Net Sell 1 txn

Insider Saintil Merline

Role Director

Sold 15,000 shs ($975K)

Type	Security	Shares	Price	Value
Sale	Common Stock	15,000	$65.00	$975K

Holdings After Transaction: Common Stock — 398,529 shares (Direct)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 12/16/2025 - 06:19 PM Learn about SEC filing dates

FAQ

What insider transaction did Rocket Lab (RKLB) disclose in this Form 4?

Rocket Lab disclosed that director Merline Saintil sold 15,000 shares of Rocket Lab common stock on 12/12/2025 at a price of $65 per share.

Who is the reporting person in this Rocket Lab (RKLB) Form 4 filing?

The reporting person is Merline Saintil, who is identified as a director of Rocket Lab Corp.

How many Rocket Lab (RKLB) shares does Merline Saintil own after the transaction?

Following the reported sale, Merline Saintil beneficially owned 398,529 shares of Rocket Lab common stock.

Was Merline Saintil’s Rocket Lab (RKLB) ownership reported as direct or indirect?

The filing shows that the 398,529 shares of Rocket Lab common stock are held with direct (D) ownership.

What transaction code was used for the Rocket Lab (RKLB) stock sale?

The transaction was reported with code “S”, indicating a sale of Rocket Lab common stock.

Who signed the Rocket Lab (RKLB) Form 4 and when was it signed?

The Form 4 was signed by /s/ Arjun Kampani as attorney-in-fact for Merline Saintil on 12/16/2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Saintil Merline

(Last) (First) (Middle)

3881 MCGOWEN STREET

(Street)

LONG BEACH CA 90808

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Rocket Lab Corp [ RKLB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/12/2025		S		15,000	D	$65	398,529	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	By: /s/ Arjun Kampani as Attorney-in-Fact For: Merline Saintil	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.